The immune system and hormones: Review and relevance to pregnancy and contraception in women with MS

International MS Journal

Volumn 10, Issue 2, 2003, Pages 44-50

  Devonshire, V ^a   Duquette, P ^b,c   Dwosh, E ^a   Guimond, C ^a   Sadovnick, A D ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Contraception; Hormone replacement therapy; Hormones; Immune system; Multiple sclerosis; Pregnancy

Indexed keywords

CYTOKINE; ESTRIOL; ESTROGEN; GADOLINIUM; GAMMA INTERFERON; HORMONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

BREAST CANCER; CARDIOVASCULAR RISK; CELLULAR IMMUNITY; COLON CANCER; CONTRACEPTION; DISABILITY; DISEASE EXACERBATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; ORAL CONTRACEPTION; OSTEOPOROSIS; PARITY; PREGNANCY; PUERPERIUM; RELAPSE; REVIEW; RISK BENEFIT ANALYSIS; SEX RATIO; UTERUS CANCER;

B-LYMPHOCYTES; ESTROGENS; FEMALE; HLA ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; PREGNANCY; T-LYMPHOCYTES;

EID: 0037498232     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998;339:285-291.
2. Damek DM, Shuster EA. Pregnancy and multiple sclerosis: review. Mayo Clin Proc 1997; 72: 977-989.
3. Whitaker JN. Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Engl J Med 1998; 339: 339-340.
4. Ebers GC. Immunology. In: Multiple Sclerosis (Paty DW, Ebers GC, eds). Philadelphia: FA Davis Company, 1997; pp403-426.
5. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992; 10: 153-187.
6. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune disease. J Exp Med 1995; 181: 1597-1601.
7. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938-952.
8. Abramsky O. Pregnancy and multiple sclerosis. Ann Neurol 1994; 36 (Suppl): S39-S41.
9. Huizinga TW, van der Linden MW, Deneys-Laporte V, Breedveld FC. Interleukin-10 as an explanation for pregnancy induced flare in systemic lupus erythematosus and remission in rheumatoid arthritis. Rheumatology 1999; 38: 496-498.
10. Orvieto R, Achiron R, Rotstein Z, Noy S, Bar-Hava I, Achiron A. Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol 1999; 82: 191-194.
11. Jansson L, Holmdahl R. Oestrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998;47:290-301.
12. Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapse/exacerbations in multiple sclerosis: a cohort study. Acta Neurol Scand 1991; 84: 403-406.
13. Schwartz GG. Hypothesis: calcitriol mediates pregnancy's effect on multiple sclerosis. Arch Neurol 1993; 50: 455.
14. Kim S, Liva SM, Dalal MA, Verity MA, Voskuhl RR. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 1999; 52: 1220-1228.
15. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol 2000; 111: 77-85.
16. Gaillard MC, Ouvre E, Liegeois A, Lewin D. The concentration of fetal cells in maternal haematopoietic organs during pregnancy. An experimental study in mice (author's translation). J Gynecol Obstet Biol Reprod (Paris) 1978; 7: 1043-1050.
17. Willer CJ, Sadovnick AD, Ebers GC. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 2002; 126: 126-133.
18. Villard-Mackintosh L, Vessey MP. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 1993; 47: 161-168.
19. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118: 253-261.
20. Poser S, Raun NE, Wikstrom J, Poser W. Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 1979; 59: 108-118.
21. Roullet E, Verdier-Toillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remitting patients. J Neurol Neurosurg Psychiatry 1993; 56: 1062-1065.
22. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. Neuroimmunol 2000; 111: 77-85.
23. Hernan MA, Hohol MJ, Olek MJ, piegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000; 55: 848-854.
24. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999; 283:1277-1278.
25. Thorogood M, Hannaford PC. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gyn 1998; 105: 1296-1299.
26. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52: 421-428.
27. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288: 321-333.
28. Duquette P. Hormonal factors in multiple sclerosis. Int MS J 2002;9:16-25.